(Q90752920)

PubMed ID

32227493

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

review article

1 reference

title

Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19 (English)

1 reference

PubMed ID

32227493

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

author name string

Hai Zhu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Nga Sze Amanda Mak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Yongqi Yan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Yi Zhu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

publication date

30 March 2020

1 reference

PubMed ID

32227493

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

16 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

27 May 2020

cites work

1 reference

12 December 2020

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

12 December 2020

Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology.

1 reference

12 December 2020

RNA virus error catastrophe: direct molecular test by using ribavirin

1 reference

12 December 2020

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

12 December 2020

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

12 December 2020

Identification of severe acute respiratory syndrome in Canada

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

1 reference

12 December 2020

Ribavirin in the treatment of SARS: A new trick for an old drug?

1 reference

12 December 2020

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

12 December 2020

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

12 December 2020

Mechanisms of action of ribavirin against distinct viruses

1 reference

12 December 2020

SARS: systematic review of treatment effects

1 reference

12 December 2020

Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin

1 reference

12 December 2020

Ribavirin modulates the conversion of human CD4(+) CD25(-) T cell to CD4(+) CD25(+) FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cell

1 reference

12 December 2020

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

1 reference

12 December 2020

Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.

1 reference

12 December 2020

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

1 reference

12 December 2020

Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome

1 reference

12 December 2020

Dynamic changes in CD45RA(-)Foxp3(high) regulatory T-cells in chronic hepatitis C patients during antiviral therapy

1 reference

12 December 2020

The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness.

1 reference

12 December 2020

A review of treatment modalities for Middle East Respiratory Syndrome

1 reference

12 December 2020

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

1 reference

12 December 2020

The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015.

1 reference

12 December 2020

Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome

1 reference

12 December 2020

Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA.

1 reference

12 December 2020

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.

1 reference

12 December 2020

Corticosteroids as adjunctive therapy in the treatment of influenza

1 reference

12 December 2020

Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection

1 reference

12 December 2020

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

1 reference

12 December 2020

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

1 reference

12 December 2020

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

12 December 2020

Drug treatment options for the 2019-new coronavirus (2019-nCoV)

1 reference

12 December 2020

First Case of 2019 Novel Coronavirus in the United States

1 reference

12 December 2020

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

12 December 2020

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

12 December 2020

A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

1 reference

12 December 2020

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

1 reference

12 December 2020

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

1 reference

12 December 2020

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV

1 reference

12 December 2020

Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR

1 reference

12 December 2020

Early lessons from the frontline of the 2019-nCoV outbreak

1 reference

12 December 2020

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies

1 reference

12 December 2020

Identifiers

DOI

10.1002/JMV.25798

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

0 references

0 references

Dimensions Publication ID

1125973707

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32227493%20AND%20SRC:MED&resulttype=core&format=json